Antipsychotic management in general practice: serial cross-sectional study (2011-2020)
- PMID: 39304310
- PMCID: PMC11614393
- DOI: 10.3399/BJGP.2024.0367
Antipsychotic management in general practice: serial cross-sectional study (2011-2020)
Abstract
Background: Long-term use of antipsychotics confers increased risk of cardiometabolic disease. Ongoing need should be reviewed regularly by psychiatrists.
Aim: To explore trends in antipsychotic management in general practice, and the proportions of patients prescribed antipsychotics receiving psychiatrist review.
Design and setting: Serial cross-sectional study using linked general practice and hospital data in Wales (2011-2020).
Method: Participants were adults (aged ≥18 years) registered with general practices in Wales. Outcome measures were prevalence of patients receiving ≥6 antipsychotic prescriptions annually, the proportion of patients prescribed antipsychotics receiving annual psychiatrist review, and the proportion of patients prescribed antipsychotics who were registered on the UK serious mental illness, depression, and/or dementia registers, or not on any of these registers.
Results: Prevalence of adults prescribed long-term antipsychotics increased from 1.055% (95% confidence interval [CI] = 1.041 to 1.069) in 2011 to 1.448% (95% CI = 1.432 to 1.464) in 2020. The proportion receiving annual psychiatrist review decreased from 59.6% (95% CI = 58.9 to 60.4) in 2011 to 52.0% (95% CI = 51.4 to 52.7) in 2020. The proportion of overall antipsychotic use prescribed to patients on the serious mental illness register decreased from 50.0% (95% CI = 49.4 to 50.7) in 2011 to 43.6% (95% CI = 43.0 to 44.1) by 2020.
Conclusion: Prevalence of long-term antipsychotic use is increasing. More patients are managed by GPs without psychiatrist review and are not on monitored disease registers; they thus may be less likely to undergo cardiometabolic monitoring and miss opportunities to optimise or deprescribe antipsychotics. These trends pose risks for patients and need to be addressed urgently.
Keywords: antipsychotics; cardiometabolic risk factors; cross-sectional studies; general practice; medication review; psychiatry.
© The Authors.
Conflict of interest statement
Alan Woodall, Lauren E Walker, Iain Buchan, and Frances S Mair receive funding from the NIHR DynAIRx project (reference: NIHR 203986) investigating the use of artificial intelligence to optimise prescribing. Iain Buchan has acted as an advisor to AstraZeneca plc, on behalf of the University of Liverpool. The other authors have declared no competing interests.
Similar articles
-
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543555
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3. Cochrane Database Syst Rev. 2017. PMID: 28791693 Free PMC article.
-
Antipsychotics for fibromyalgia in adults.Cochrane Database Syst Rev. 2016 Jun 2;2016(6):CD011804. doi: 10.1002/14651858.CD011804.pub2. Cochrane Database Syst Rev. 2016. PMID: 27251337 Free PMC article.
-
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2. Cochrane Database Syst Rev. 2021. PMID: 34918337 Free PMC article.
-
Atypical antipsychotics for psychosis in adolescents.Cochrane Database Syst Rev. 2013 Oct 15;2013(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Cochrane Database Syst Rev. 2013. PMID: 24129841 Free PMC article.
Cited by
-
Twenty-five year trend in antipsychotic medication prescribing in England: challenges and opportunities.BJPsych Open. 2025 Jul 16;11(4):e151. doi: 10.1192/bjo.2025.10073. BJPsych Open. 2025. PMID: 40665640 Free PMC article.
-
'Flattened, fattened, and forgotten': the 'dis-integrated' care of patients prescribed antipsychotics in the UK.Br J Gen Pract. 2024 Dec 26;75(750):9-10. doi: 10.3399/bjgp25X740397. Print 2025 Jan. Br J Gen Pract. 2024. PMID: 39725528 No abstract available.
References
-
- Joint Formulary Committee British National Formulary. 2024 https://bnf.nice.org.uk (accessed 19 Nov 2024). - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources